Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents
- 1 March 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (6) , 1496-1501
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- TuberculosisNew England Journal of Medicine, 2013
- Linezolid for Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2013
- Linezolid for Treatment of Chronic Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2012
- Synthesis and Biological Evaluation of 2-(3-Fluoro-4-nitro phenoxy)-N-phenylacetamide Derivatives as Novel Potential Affordable Antitubercular AgentsMolecules, 2012
- The oxazolidinones: past, present, and futureAnnals of the New York Academy of Sciences, 2011
- Current Status and Research Strategies in Tuberculosis Drug DevelopmentJournal of Medicinal Chemistry, 2011
- The challenge of new drug discovery for tuberculosisNature, 2011
- Oxazolidinone Antibacterials and Our ExperienceAnti-Infective Agents, 2008
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- The Synthesis of N-Aryl-5(S)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl CarbamatesOrganic Process Research & Development, 2003